Prominence of the dopamine D2 short isoform in dopaminergic pathways.
about
Dopamine release in the basal gangliaDopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptorDopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin AIntegrated signaling in heterodimers and receptor mosaics of different types of GPCRs of the forebrain: relevance for schizophreniaLooking for the role of cannabinoid receptor heteromers in striatal functionNuclear localization of L-type glutaminase in mammalian brainMidbrain dopamine receptor availability is inversely associated with novelty-seeking traits in humansANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuseThe dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction.Ligand-induced regulation and localization of cannabinoid CB1 and dopamine D2L receptor heterodimersThe interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: a principal component analysis of [18F]fallypride bindingAlcoholism and alternative splicing of candidate genesDopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathwayHigh-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocolA positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment.An astroglia-linked dopamine D2-receptor action in prefrontal cortex.Control of lactotrop proliferation by dopamine: essential role of signaling through D2 receptors and ERKs.A Drosophila dopamine 2-like receptor: Molecular characterization and identification of multiple alternatively spliced variants.Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse.Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites.Loss of dopamine D2 receptors increases parvalbumin-positive interneurons in the anterior cingulate cortex.Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2.Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users.mRNA transcript diversity creates new opportunities for pharmacological intervention.DRD2 polymorphisms modulate reward and emotion processing, dopamine neurotransmission and openness to experienceDistinct regulation of dopamine D2S and D2L autoreceptor signaling by calcium.Dopamine D(2) Antagonist-Induced Striatal Nur77 Expression Requires Activation of mGlu5 Receptors by Cortical AfferentsReversal of quinpirole inhibition of ventral tegmental area neurons is linked to the phosphatidylinositol system and is induced by agonists linked to G(q).Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory.Network-Dependent Modulation of COMT and DRD2 Polymorphisms in Healthy Young Adults.Functional Genetic Variation in Dopamine Signaling Moderates Prefrontal Cortical Activity During Risky Decision Making.Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene-gene-environment interactionThe role of mesocorticolimbic dopamine in regulating interactions between drugs of abuse and social behavior.Evidence for Noncanonical Neurotransmitter Activation: Norepinephrine as a Dopamine D2-Like Receptor AgonistParadoxical dopaminergic drug effects in extraversion: dose- and time-dependent effects of sulpiride on EEG theta activityInsights into the role of dopamine receptor systems in learning and memory.Identification of G protein-coupled receptors required for vitellogenin uptake into the oocytes of the red flour beetle, Tribolium castaneum.Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia.Cannabinoid-induced enhanced interaction and protein levels of serotonin 5-HT(2A) and dopamine D₂ receptors in rat prefrontal cortex.D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling
P2860
Q22251247-B77BBAF1-4FC2-4EC6-AEFE-3E0462114465Q24300744-D6EEEB6D-05C1-4478-ACBA-D0E1A75C2543Q24604923-5D86F6FB-5FB7-45BB-8655-62056BA3F294Q24632803-F0ABA5BE-1B4F-463F-8798-AB7999907782Q24658338-6F4B64D6-40B5-40B8-8D17-6EA9CC612A21Q28217014-22E954B5-1B3E-4F71-8E33-FF305AB58FFFQ30490410-0E068FF0-7C96-4474-9382-142E4A0CD3B8Q33578546-A793F877-D470-4B44-BE1F-8E5754AFD30BQ33579769-7300C10C-6441-42B9-A232-F782CA492C2FQ33714838-A4983444-5D0B-4891-998C-AFF2BAEE8A68Q33821967-CCFD7667-5915-4C12-9BBB-ADD19FCE027BQ33859015-3817FBCC-F30D-44F2-A2F8-2212466BD177Q33888216-B9D8DFB5-78E2-47E7-83B4-5ABD888B041AQ33964443-D6E93867-CA6D-43BC-A514-81A04F24D747Q34017591-300532CF-2117-4734-9C90-AAA53F1E1153Q34115031-4F4CACED-4474-40F3-87A4-01336F46E88AQ34394799-8FD864BD-EC0E-43F9-939B-A02BEFAB375FQ34394954-C6FFDF3C-C8BE-4586-94FE-A8D9BCC81ADCQ34662050-132E6E2D-EC7F-48E5-8F15-E827135EEA2EQ34923951-72A47F86-8AB2-4274-A8F3-120882182EB1Q35212984-F8AF4AF1-4917-464B-8D7D-F81F64963782Q35626928-FB1EF517-0634-48F4-AE47-66938B3F0B7AQ35634676-402F3169-14E1-452D-BB27-F231484A0B40Q35913120-5B8FFA65-7932-4DDA-A02A-AFB1A6D8AF8AQ36054572-DD4E79AD-5106-4FBE-837D-8DA45B932BD6Q36075672-A13DC8A4-A049-427F-84E1-365E5F42BBA1Q36162473-48E6972F-BBB4-4856-8F4E-0A0077B1772AQ36211286-EA55CD9D-12E6-45DA-B0C4-B41C351925A3Q36300098-3370D085-E586-4FD9-AB2E-4C120F47AA79Q36353466-EF5051F5-BBA7-405A-859B-7E9A01F98619Q36449651-E34B802D-B206-45D0-9D6A-002C2DA2874CQ36593856-262C401E-26FC-4B58-9768-027F57A6ABFCQ36627836-8BC8846A-8962-4AFD-A1D7-1D5F2EC50042Q36733481-266F8C45-259C-474C-B435-39737F4576A4Q36747324-63B1CB0D-C87F-4E41-B9CA-C71126FC8AABQ36778973-0E2D72F9-4121-460B-B507-5589193D76E0Q36986026-1AC3AD23-17E6-4B45-A1A8-825BE920B0BDQ37092462-5D32EE97-063F-41F3-9D88-CD767219C360Q37104197-51FDCDCE-DE6D-4294-85DE-A70997D24AD9Q37130639-3FB573D8-4474-469A-998C-FC48109222B0
P2860
Prominence of the dopamine D2 short isoform in dopaminergic pathways.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Prominence of the dopamine D2 short isoform in dopaminergic pathways.
@ast
Prominence of the dopamine D2 short isoform in dopaminergic pathways.
@en
type
label
Prominence of the dopamine D2 short isoform in dopaminergic pathways.
@ast
Prominence of the dopamine D2 short isoform in dopaminergic pathways.
@en
prefLabel
Prominence of the dopamine D2 short isoform in dopaminergic pathways.
@ast
Prominence of the dopamine D2 short isoform in dopaminergic pathways.
@en
P2093
P2860
P356
P1476
Prominence of the dopamine D2 short isoform in dopaminergic pathways.
@en
P2093
P2860
P304
P356
10.1073/PNAS.95.13.7731
P407
P577
1998-06-01T00:00:00Z